Journal
Science advances
Publication Date
5-12-2023
Volume
9
Issue
19
First Page
eade3559
Document Type
Open Access Publication
DOI
10.1126/sciadv.ade3559
Rights and Permissions
Sun R, Han R, McCornack C, Khan S, Tabor GT, Chen Y, Hou J, Jiang H, Schoch KM, Mao DD, Cleary R, Yang A, Liu Q, Luo J, Petti A, Miller TM, Ulrich JD, Holtzman DM, Kim AH. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma. Sci Adv. 2023 May 12;9(19):eade3559. doi: 10.1126/sciadv.ade3559 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
Recommended Citation
Sun, Rui; Han, Rowland; McCornack, Colin; Khan, Saad; Tabor, G Travis; Chen, Yun; Hou, Jinchao; Jiang, Haowu; Schoch, Kathleen M; Mao, Diane D; Cleary, Ryan; Yang, Alicia; Liu, Qin; Luo, Jingqin; Petti, Allegra; Miller, Timothy M; Ulrich, Jason D; Holtzman, David M; and Kim, Albert H, "TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma." Science advances. 9, 19. eade3559 (2023).
https://digitalcommons.wustl.edu/oa_4/2018
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
